Expression analysis and clinical correlation of aquaporin 1 and 4 genes in human hippocampal sclerosis


Bebek N. , Özdemir Ö., Sayitoglu M. , Hatirnaz O. , Baykan B. , Gurses C. , ...Daha Fazla

JOURNAL OF CLINICAL NEUROSCIENCE, cilt.20, ss.1564-1570, 2013 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 20 Konu: 11
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1016/j.jocn.2012.12.023
  • Dergi Adı: JOURNAL OF CLINICAL NEUROSCIENCE
  • Sayfa Sayıları: ss.1564-1570

Özet

Mesial temporal sclerosis (MTS) is the most frequent cause of drug resistant symptomatic partial epilepsy. The mechanism and genetic background of this unique pathology are not well understood. Aquaporins (AQP) are regulators of water homeostasis in the brain and are expressed in the human hippocampus. We explored the role of AQP genes in the pathogenetic mechanisms of MTS through an evaluation of gene expression in surgically removed human brain tissue. We analyzed AQP1 and 4 mRNA levels by quantitative real-time polymerase chain reaction and normalized to ABL and cyclophilin genes, followed by immunohistochemistry for AQP4. Relative expressions were calculated according to the delta Ct method and the results were compared using the Mann-Whitney U test. Brain specimens of 23 patients with epilepsy who had undergone surgery for MTS and seven control autopsy specimens were investigated. Clinical findings were concordant with previous studies and 61% of the patients were seizure-free in the postoperative period. AQP1 and 4 gene expression levels did not differ between MTS patients and control groups. Immunofluorescence analysis of AQP4 supported the expression results, showing no difference. Previous studies have reported contradictory results about the expression levels of AQP in MTS. To our knowledge, only one study has suggested upregulation whereas the other indicated downregulation of perivascular AQP4. Our study did not support these findings and may rule out the involvement of AQP in human MTS. (C) 2013 Elsevier Ltd. All rights reserved.